Puerto Rico’s primary healthcare and medical research institution becomes the 28th member of Caris’ collaborative network dedicated to making cancer treatment more precise and effective.
Caris Life Sciences is featured in the latest Newsweek feature/cover story. The article provides an overview of the current state of precision oncology (growing interest and abilities, but underutilized), addresses challenges (doctors lacking expertise in the area and expense/reimbursement issues, clinical trial enrollment for new drugs) and also highlights opportunities – with a keen focus … Read More
Averbuch, recently retired Vice President and Head of Precision Medicine at Bristol-Myers Squibb, brings more than 35 years of oncology drug and companion diagnostic development experience to Caris’ Scientific Advisory Board IRVING, Texas, July 03, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced … Read More
Caris Life Sciences’ Precision Oncology Alliance Publishes New Review of Molecular Testing in Cancer
Paper by collaborative network of clinicians and researchers examines the evolution of molecular profiling for metastatic solid tumors, providing a comprehensive overview of the state of precision oncology today IRVING, Texas, June 6, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on precision medicine, today announced the publication of a seminal paper … Read More
IRVING, Texas, June 4, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced that Brian J. Brille, Vice Chairman of the Company, will present at the Jefferies 2019 Healthcare Conference on Friday, June 7, 2019, at 8:30 a.m. Eastern time. The conference is … Read More